Cargando…

The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer

BACKGROUND: The controversy regarding optimal clinical T2N0 esophageal cancer treatment ultimately stems from the clinical staging modalities’ inaccuracy. Because most inaccuracies lie in clinical T2 to pathological T1, it is vital to discriminate whether the muscularis propria is invaded. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dong, Liu, Guobing, Jiang, Dongxian, Yu, Yangli, Wang, Hao, Shi, Hongcheng, Tan, Lijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867900/
https://www.ncbi.nlm.nih.gov/pubmed/33569414
http://dx.doi.org/10.21037/atm-20-4430
_version_ 1783648369410834432
author Lin, Dong
Liu, Guobing
Jiang, Dongxian
Yu, Yangli
Wang, Hao
Shi, Hongcheng
Tan, Lijie
author_facet Lin, Dong
Liu, Guobing
Jiang, Dongxian
Yu, Yangli
Wang, Hao
Shi, Hongcheng
Tan, Lijie
author_sort Lin, Dong
collection PubMed
description BACKGROUND: The controversy regarding optimal clinical T2N0 esophageal cancer treatment ultimately stems from the clinical staging modalities’ inaccuracy. Because most inaccuracies lie in clinical T2 to pathological T1, it is vital to discriminate whether the muscularis propria is invaded. METHODS: We investigated the association between the primary tumor maximal standard uptake value (SUVmax), and the pathological features and overall survival. We attempted to construct a discriminative model through logistic regression analysis. RESULTS: A total of 140 cN0 esophageal squamous cell carcinoma (ESCC) patients were enrolled. Primary tumor SUVmax differed significantly in paired pathological T categories (P<0.05), but not pT2 vs. pT3 (P=0.648). Age (≤65 vs. >65), biopsy differentiation grades (well or moderately vs. poorly vs. unknown), and primary tumor SUVmax (continuous) were independent risk factors for invasion depth. Subsequently, the age categories, the biopsy differentiation grade categories, and the primary tumor SUVmax categories (≤7.4 vs. >7.4) were included in the logistic regression analysis to construct a discriminative model, showing a good performance in discriminating pT2–3 vs. pT1 in terms of accuracy 87.1%, sensitivity 93.6%, specificity 73.9%, and area under the curve (AUC) 0.887 [95% confidence interval (CI): 0.822 to 0.951]. Of these factors, biopsy differentiation grades and primary tumor SUVmax showed significant differences in overall survival (P<0.05), while the age categories did not. CONCLUSIONS: The novel baseline model comprised of age, biopsy differentiation grades, and primary tumor SUVmax provide much discriminative performance in determining whether the muscularis propria is invaded. Further studies are necessary to validate the findings and guide clinical practice for cT2N0 esophageal cancer.
format Online
Article
Text
id pubmed-7867900
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-78679002021-02-09 The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer Lin, Dong Liu, Guobing Jiang, Dongxian Yu, Yangli Wang, Hao Shi, Hongcheng Tan, Lijie Ann Transl Med Original Article BACKGROUND: The controversy regarding optimal clinical T2N0 esophageal cancer treatment ultimately stems from the clinical staging modalities’ inaccuracy. Because most inaccuracies lie in clinical T2 to pathological T1, it is vital to discriminate whether the muscularis propria is invaded. METHODS: We investigated the association between the primary tumor maximal standard uptake value (SUVmax), and the pathological features and overall survival. We attempted to construct a discriminative model through logistic regression analysis. RESULTS: A total of 140 cN0 esophageal squamous cell carcinoma (ESCC) patients were enrolled. Primary tumor SUVmax differed significantly in paired pathological T categories (P<0.05), but not pT2 vs. pT3 (P=0.648). Age (≤65 vs. >65), biopsy differentiation grades (well or moderately vs. poorly vs. unknown), and primary tumor SUVmax (continuous) were independent risk factors for invasion depth. Subsequently, the age categories, the biopsy differentiation grade categories, and the primary tumor SUVmax categories (≤7.4 vs. >7.4) were included in the logistic regression analysis to construct a discriminative model, showing a good performance in discriminating pT2–3 vs. pT1 in terms of accuracy 87.1%, sensitivity 93.6%, specificity 73.9%, and area under the curve (AUC) 0.887 [95% confidence interval (CI): 0.822 to 0.951]. Of these factors, biopsy differentiation grades and primary tumor SUVmax showed significant differences in overall survival (P<0.05), while the age categories did not. CONCLUSIONS: The novel baseline model comprised of age, biopsy differentiation grades, and primary tumor SUVmax provide much discriminative performance in determining whether the muscularis propria is invaded. Further studies are necessary to validate the findings and guide clinical practice for cT2N0 esophageal cancer. AME Publishing Company 2021-01 /pmc/articles/PMC7867900/ /pubmed/33569414 http://dx.doi.org/10.21037/atm-20-4430 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Lin, Dong
Liu, Guobing
Jiang, Dongxian
Yu, Yangli
Wang, Hao
Shi, Hongcheng
Tan, Lijie
The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer
title The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer
title_full The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer
title_fullStr The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer
title_full_unstemmed The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer
title_short The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer
title_sort role of primary tumor suvmax in the diagnosis of invasion depth: a step toward clinical t2n0 esophageal cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867900/
https://www.ncbi.nlm.nih.gov/pubmed/33569414
http://dx.doi.org/10.21037/atm-20-4430
work_keys_str_mv AT lindong theroleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT liuguobing theroleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT jiangdongxian theroleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT yuyangli theroleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT wanghao theroleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT shihongcheng theroleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT tanlijie theroleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT lindong roleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT liuguobing roleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT jiangdongxian roleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT yuyangli roleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT wanghao roleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT shihongcheng roleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer
AT tanlijie roleofprimarytumorsuvmaxinthediagnosisofinvasiondepthasteptowardclinicalt2n0esophagealcancer